You have 9 free searches left this month | for more free features.

Condition

GI Cancer (1)

Solid Tumors (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Curegenix Inc. (1)

Collaborator

Merck Sharp & Dohme Corp. (1)

Intervention

cetuximab (1)

cgx1321 (1)

encorafenib (1)

pembrolizumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

cgx1321

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Solid Tumors, GI Cancer Trial in Taiwan, United States (CGX1321, Pembrolizumab, encorafenib)

Recruiting

Solid Tumors
GI Cancer

CGX1321
+3 more

Long Beach, California
+25 more

Jan 11, 2022